pinocembrin has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L; Jin, X; Li, M; Liu, Q; Wang, X | 1 |
| Chen, HB; Dang, YY; Fu, JJ; Jia, XJ; Lee, SM; Li, CW; Wang, XF; Zhang, Q; Zou, ZC | 1 |
2 other study(ies) available for pinocembrin and oxidopamine
| Article | Year |
|---|---|
Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells.
Topics: Antioxidant Response Elements; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Flavanones; Humans; Neurons; NF-E2-Related Factor 2; Oxidopamine; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction | 2015 |
Pinocembrin-7-Methylether Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction Through AKT and ERK Pathways.
Topics: Animals; Cell Line, Tumor; DNA Fragmentation; Dopaminergic Neurons; Dose-Response Relationship, Drug; Flavanones; Humans; MAP Kinase Signaling System; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Proto-Oncogene Proteins c-akt; Zebrafish; Zebrafish Proteins | 2021 |